PolyPeptide Group AG (XSWX:PPGN) EPS (Basic) : CHF-1.51 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG EPS (Basic)?

PolyPeptide Group AG's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was CHF-0.49. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-1.51.

PolyPeptide Group AG's EPS (Diluted) for the six months ended in Dec. 2023 was CHF-0.49. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-1.51.

PolyPeptide Group AG's EPS without NRI for the six months ended in Dec. 2023 was CHF-0.49. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -1.51.

During the past 12 months, PolyPeptide Group AG's average EPS without NRIGrowth Rate was -720.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, PolyPeptide Group AG's highest 3-Year average EPS without NRI Growth Rate was 27.90% per year. The lowest was -36.80% per year. And the median was -4.45% per year.

PolyPeptide Group AG EPS (Basic) Historical Data

The historical data trend for PolyPeptide Group AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG EPS (Basic) Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.94

1.12

1.53

0.24

-1.47

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial					0.71	0.32	-0.07	-1.02	-0.49

PolyPeptide Group AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PolyPeptide Group AG's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-48.512	-	0)	/	32.941
	=	-1.47

PolyPeptide Group AG's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.196	-	0)	/	32.934
	=	-0.49

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-1.51

PolyPeptide Group AG (XSWX:PPGN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PolyPeptide Group AG EPS (Basic) Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines